104 related articles for article (PubMed ID: 4402999)
21. Influence of pKa on the biotransformation of indene H1-antihistamines by CYP2D6.
Huang C; Moree WJ; Zamani-Kord S; Li BF; Tucci FC; Malany S; Wen J; Wang H; Hoare SR; Yang C; Madan A; Crowe PD; Beaton G
Bioorg Med Chem Lett; 2011 Feb; 21(3):947-51. PubMed ID: 21232954
[TBL] [Abstract][Full Text] [Related]
22. Optical isomers of rocastine and close analogues: synthesis and H1 antihistaminic activity of its enantiomers and their structural relationship to the classical antihistamines.
Sleevi MC; Cale AD; Gero TW; Jaques LW; Welstead WJ; Johnson AF; Kilpatrick BF; Demian I; Nolan JC; Jenkins H
J Med Chem; 1991 Apr; 34(4):1314-28. PubMed ID: 1673158
[TBL] [Abstract][Full Text] [Related]
23. Potential histamine H2-receptor antagonists. 3. Methylhistamines.
Durant GJ; Emmett JC; Ganellin CR; Roe AM; Slater RA
J Med Chem; 1976 Jul; 19(7):923-8. PubMed ID: 7675
[TBL] [Abstract][Full Text] [Related]
24. Solution conformations of antihistamines.
Ham NS
J Pharm Sci; 1971 Nov; 60(11):1764-5. PubMed ID: 4399982
[No Abstract] [Full Text] [Related]
25. Synthesis of 2-(4-substituted-1-piperazinyl)benzimidazoles as H1-antihistaminic agents.
Iemura R; Kawashima T; Fukuda T; Ito K; Tsukamoto G
J Med Chem; 1986 Jul; 29(7):1178-83. PubMed ID: 2879912
[TBL] [Abstract][Full Text] [Related]
26. Antiviral benzimidazoles. Direct 1-substitution of 2-(- -hydroxybenzyl)benzimidazole and related compounds.
O'Sullivan DG; Wallis AK
J Med Chem; 1972 Jan; 15(1):103-4. PubMed ID: 5007078
[No Abstract] [Full Text] [Related]
27. Synthesis and pharmacological investigation of novel 4-benzyl-1-substituted-4H-[1,2,4]triazolo[4,3-a]quinazolin-5-ones as new class of H1-antihistaminic agents.
Alagarsamy V; Solomon VR; Murugan M
Bioorg Med Chem; 2007 Jun; 15(12):4009-15. PubMed ID: 17452107
[TBL] [Abstract][Full Text] [Related]
28. Expedient synthesis of mequitazine an antihistaminic drug by palladium catalyzed allylic alkylation of sodium phenothiazinate.
Gonnot V; Nicolas M; Mioskowski C; Baati R
Chem Pharm Bull (Tokyo); 2009 Nov; 57(11):1300-2. PubMed ID: 19881287
[TBL] [Abstract][Full Text] [Related]
29. The discovery and structure-activity relationships of 2-(piperidin-3-yl)-1H-benzimidazoles as selective, CNS penetrating H1-antihistamines for insomnia.
Lavrador-Erb K; Ravula SB; Yu J; Zamani-Kord S; Moree WJ; Petroski RE; Wen J; Malany S; Hoare SR; Madan A; Crowe PD; Beaton G
Bioorg Med Chem Lett; 2010 May; 20(9):2916-9. PubMed ID: 20347297
[TBL] [Abstract][Full Text] [Related]
30. Antiallergic agents. 2. N-(1H-tetrazol-5-yl)-6-phenyl-2-pyridinecarboxamides.
Honma Y; Oda K; Hashiyama T; Hanamoto K; Nakai H; Inoue H; Ishida A; Takeda M; Ono Y; Tsuzurahara K
J Med Chem; 1983 Oct; 26(10):1499-504. PubMed ID: 6137568
[TBL] [Abstract][Full Text] [Related]
31. Derivatives of 10,11-dihydro-5H-dibenzo(a,d)cycloheptene and related compounds. 6. Aminoalkyl derivatives of the aza isosteres.
Villani FJ; Daniels PJ; Ellis CA; Mann TA; Wang KC; Wefer EA
J Med Chem; 1972 Jul; 15(7):750-4. PubMed ID: 4402943
[No Abstract] [Full Text] [Related]
32. Potential histamine H2-receptor antagonists. 2. N-alpha-Guanylhistamine.
Durant GJ; Parsons ME; Black JW
J Med Chem; 1975 Aug; 18(8):830-3. PubMed ID: 240023
[TBL] [Abstract][Full Text] [Related]
33. [(3-Pyridylalkyl)piperidylidene]benzocycloheptapyridine derivatives as dual antagonists of PAF and histamine.
Carceller E; Merlos M; Giral M; Balsa D; Almansa C; Bartrolí J; García-Rafanell J; Forn J
J Med Chem; 1994 Aug; 37(17):2697-703. PubMed ID: 7914928
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and properties of some hypotensive N-alkylaminopropionic esters and N,N-dialkylaminopropionic esters and their hydroxamic acids.
Coutts RT; Hubbard JW; Midha KK; Prasad K
J Pharm Sci; 1971 Jan; 60(1):28-33. PubMed ID: 5548238
[No Abstract] [Full Text] [Related]
35. Synthesis of 4-[p-[(2-chloroethyl)-(2-hydroxyethyl)amino]phenyl]butyric acid and its behavior in the 4-(4-nitrobenzyl)pyridine assay procedure.
Balazs MK; Anderson CA; Iwamoto RH; Lim P
J Pharm Sci; 1970 Apr; 59(4):563-5. PubMed ID: 5440691
[No Abstract] [Full Text] [Related]
36. Synthesis of the N-oxides of some drugs.
Pomorski J
Arch Immunol Ther Exp (Warsz); 1967; 15(2):249-57. PubMed ID: 4383091
[No Abstract] [Full Text] [Related]
37. Structural influences upon antihistamine activity; 3-amino-1-aryl-1-(2-pyridyl)propenes and related compounds.
Ison RR; Casy AF
J Pharm Pharmacol; 1971 Nov; 23(11):848-56. PubMed ID: 4400193
[No Abstract] [Full Text] [Related]
38. Synthesis and pharmacological investigation of novel 4-(3-ethylphenyl)-1-substituted-4H-[1,2,4]triazolo[4,3-a] quinazolin-5-ones as a new class of H1-antihistaminic agents.
Alagarsamy V; Kavitha K; Rupeshkumar M; Solomon VR; Kumar J; Kumar DS; Sharma HK
Acta Pharm; 2009 Mar; 59(1):97-106. PubMed ID: 19304562
[TBL] [Abstract][Full Text] [Related]
39. The discovery of quinoline based single-ligand human H
Procopiou PA; Ancliff RA; Gore PM; Hancock AP; Hodgson ST; Holmes DS; Keeling SP; Looker BE; Parr NA; Rowedder JE; Slack RJ
Bioorg Med Chem Lett; 2016 Dec; 26(24):5855-5859. PubMed ID: 27866818
[TBL] [Abstract][Full Text] [Related]
40. 4-(3-Methoxyphenyl)-1-substituted-4H-[1,2,4]triazolo[4,3-a]quinazolin-5-ones: new class of H1-antihistaminic agents.
Alagarsamy V; Sharma HK; Parthiban P; Singh JC; Murugan ST; Solomon VR
Pharmazie; 2009 Jan; 64(1):5-9. PubMed ID: 19216223
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
